The Anticoagulation Forum is proud to have converted our newsletter to an electronic delivery system and we are no longer generating or sending paper copies. If you wish to receive the newsletter, please subscribe by joining the AC Forum.
Content from our newsletters is also put on our website as a way to share information for the mutual growth and development of professionals in the anticoagulation field.
This issue announces the launch of the Anticoagulation Centers of Excellence website. This program has been created to help healthcare professionals provide the highest level of care, and achieve the best possible outcomes for their patients on antithrombotic medications.
In this issue, outgoing AC Forum President Dr. David Garcia offers his thoughts on his nearly six years heading the organization, and introduces Dr. Mark Crowther as the new President of the AC Forum.
In this issue, the AC Forum announces its new initiative, called "Anticoagulation Centers of Excellence". Plans are underway to build a comprehensive website and an interactive assessment tool that will help to define the ideal practices a clinic should be using to provide the best possible care.
In this issue, Boston University School of Medicine Continuing Medical Education, in partnership with the Anticoagulation Forum, announces that it is sponsoring a nationwide series of grand rounds meetings for community hospitals on using anticoagulation therapy for preventing stroke in patients with atrial fibrillation.
This issue includes information on the patient track for THNSA. The half-day patient track will consist of a Stop The ClotŪ Forum, an interactive program that provides basic information about blood clots, signs and symptoms, risk factors, prevention and treatment.
This issue introduces 'Ask Janet', a monthly column answering questions posed by Anticoagulation Forum members.
This issue announces changes to the AC Forum Board of Directors, registration information for THSNA, VDC's endorsement of THSNA, application information for nursing scholarships to attend THSNA and NCBAP seeking a physician to serve of its Board of Directors.
This issue announces NHF as a collaborative partner and the endorsements and support of ISTH, CDC, AHA and VDC in THSNA.
This issue announces a webinar on the FDA's approval of rivaroxaban, highlights THSNA deadlines and opportunities, and includes an anticoagulation clinic case vignette and National Certification Board for Anticoagulation Providers update.
This issue includes THSNA reminders, an invitation to participate in the BRIDGE clinical study, and news about a new foundation advancing correct diagnosis and optimal treatment of women and girls with blood disorders.
This issue contains information about AC Forum’s new conference - the Thrombosis and Hemostasis Summit of North America (THSNA), a call for abstracts for the THSNA conference, a successful clinic vignette, and updates from Clot Connect and the National Blood Clot Alliance.
Register by March 15th to avoid late fees .
Early Bird registration rate expiring soon.
Call for abstracts for presentation at the 11th National Conference.
11th National Conference Registration now open.
This issue includes an article about The Hemophilia & Thrombosis Research Society, updates from the NCBAP highlighting changes to the CACP process, and an announcement from the NATT Board of Directors about its new name change to the National Blood Clot Alliance. Also featured on the front page is the discussion “The Importance of the Control Group to Assess the Benefits of Home Monitoring” by Jack Ansell, M.D.
Say goodbye to conference calls and hello to latest in computer technology: the webinar. No longer do people have to move from their desks to attend a meeting. Join the AC Forum Lunch and Learn Journal Club by webinar. This issue also includes news about the AC Forum Conference, Case Vignettes, NATT Update and an NCBAP Update.
In February of 2008 a group of 24 of the nation’s leading experts in oral anticoagulation management and reimbursement, gathered to develop a guideline for healthcare professionals to provide a practical, seamless process for the implementation of patient self-testing (PST). The group was comprised of cardiologists, internist, family physicians, hematologist, RNs, Advanced Practice Nurses, PharmDs, health plan administrators and reimbursement consultants.
This special edition of the Anticoagulation Forum newsletter contains the full article titled Delivery of Optimized Anticoagulant Therapy: A Consensus Statement from the Anticoagulation Forum published in the Annals of Pharmacotherapy in July 2008. This article updates the paper published in 1997 by Jack Ansell and the Anticoagulation Guidelines Task Force titled Consensus Guidelines for Coordinated Outpatient Oral Anticoagulation Therapy Management.
This issue of the newsletter explains the billing codes and other details of the Medicare expanded coverage for INR patient home monitoring. The newsletter also includes a new column on successful anticoagulation clinics and a new issue of Anticoagulation Updates from the Literature.
This edition of the newsletter contains an informative article entitled Emerging Anticoagulants in the Management of Venous Thromboembolism by Dr. Alex Spyropoulos. Other articles include a new edition of Anticoagulation Updates from the Literature, updates from NATT and NCBAP, and the AC Forum’s new address and contact information.
This Anticoagulation Forum newsletter includes a copy of the letter sent to the Centers for Medicare and Medicaid Services in support of expanded coverage for patient self-testing, announces NATT's large grant from the CDC, and includes a chart outlining the many organizations working in the field of thrombosis.
This issue of the newsletter includes a letter from the AC Forum Board of Directors to Dr. Lawrence Lesko, Director, Office of Clinical Pharmacology at the FDA. The letter outlines the AC Forum's concerns about the FDA's plan to add information about genotype testing to the warfarin package insert. The newsletter also includes Dr. Lesko's response letter.
The Anticoagulation Forum’s 9th National Conference on May 3-5 in Chicago is just a few months away. Be sure to register soon. Dr. Jack Ansell steps down as president and Dr. David Garcia introduces his vision for the AC Forum’s future. Also included is a commentary by Mark Crowther, MD on “Fixed-Dose Unfractionated Heparin for the Treatment of Venous Thromboembolism”.
This issue features a study investigating the interaction between cranberry juice and warfarin, introduces new members of the AC Forum Board of Directors, and offers free copies of the 8th National Conference proceeding published by the Journal of Thrombosis and Thrombolysis.
This issue announces that Chicago will be the site for the next Anticoagulation Forum conference - May 3-5, 2007. Also included is an article on "Understanding the Variability of Warfarin Dosing" and updates from the National Alliance on Thrombosis and Thrombophilia (NATT) and from the National Certification Board of Anticoagulation Providers (NCBAP) including a list of the newest CACPs.
The 8th National Conference is just 2 months away. Please view the newsletter for more details. Also in this issue, Dr. Jack Ansell discusses "What Happened to Ximelagatran?" Read updates from the National Alliance for Thrombosis and Thrombophilia, the National Certification Board of Anticoagulation Providers (including information on the recertification process) and information from the NIH conference on Dietary Supplements, Coagulation, and Antithrombotic Therapies.
This edition contains new information on long-term, secondary treatment of deep venous thrombosis, a CACP credentialing update as well as details on a National Consumers League campaign to improve senior outpatient medication safety.